The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients
The aim of this research was to study the influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients. Methods. The polymorphic variants of GSTP1 gene were analyzed using Allelic Discrimination Real-Time PCR. Result...
Gespeichert in:
| Datum: | 2012 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Інститут молекулярної біології і генетики НАН України
2012
|
| Schriftenreihe: | Вiopolymers and Cell |
| Schlagworte: | |
| Online Zugang: | https://nasplib.isofts.kiev.ua/handle/123456789/156720 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Zitieren: | The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients / I.A. Kriachok, N.M. Khranovska, N.M. Svergun, K.S. Filonenko, O.I. Novosad, I.B. Titorenko, A.V. Martynchik, H.O. Gubareva, T.V. Kadnikova, O.M. Aleksik, E.V. Kushchevyy, I.V. Pastushenko // Вiopolymers and Cell. — 2012. — Т. 28, № 1. — С. 56-61. — Бібліогр.: 19 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of Ukraine| id |
nasplib_isofts_kiev_ua-123456789-156720 |
|---|---|
| record_format |
dspace |
| fulltext |
|
| spelling |
nasplib_isofts_kiev_ua-123456789-1567202025-02-09T11:01:50Z The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients Дослідження впливу поліморфізму гена GSTP1 A313G на виникнення лімфоми Ходжкіна, токсичність хіміотерапії та перебіг захворювання Исследование влияния полиморфизма гена GSTP1 A313G на возникновение лимфомы Ходжкина, токсичность химиотерапии и течение заболевания Kriachok, I.A. Khranovska, N.M. Svergun, N.M. Filonenko, K.S. Novosad, O.I. Titorenko, I.B. Martynchik, A.V. Gubareva, H.O. Kadnikova, T.V. Aleksik, O.M. Kushchevyy, E.V. Pastushenko, I.V. Biomedicine The aim of this research was to study the influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients. Methods. The polymorphic variants of GSTP1 gene were analyzed using Allelic Discrimination Real-Time PCR. Results. The GSTP1 polymorphism is not directly involved in the development of Hodgkin’s lymphoma and chemotherapy-related toxicity, but homozygous wild genotype of this gene is associated with a worse clinical response to the therapy and a higher risk of relapse. Conclusions. The investigation of GSTP1 polymorphism is very promising, since it might provide a possible application of this genetic marker as an independent prognostic factor of Hodgkin’s lymphoma. Мета. Дослідити поліморфізм гена GSTP1 A313G і визначити його вплив на виникнення лімфоми Ходжкіна, токсичність хіміотерапії, а також на перебіг захворювання. Методи. Поліморфні варіанти гена GSTP1 аналізували методом алель-специфічної ПЛР з детекцією результатів у режимі реального часу. Результати. Встановлено, що гомозиготний тип успадкування алеля дикого типу – генотип A/A – пов’язаний з несприятливим прогнозом перебігу лімфоми Ходжкіна: гіршою відповіддю на терапію і вірогідністю появи рецидивів. Висновки. Перспективним напрямком пошуку чинників впливу на перебіг хвороби є вивчення поліморфізму гена GSTP1, який у майбутньому може бути використаний як «фактор ризику» при формуванні прогностичних груп хворих та виборі тактики лікування. Цель. Исследовать полиморфизм гена GSTP1 A313G и определить его влияние на возникновение лимфомы Ходжкина, токсичность химиотерапии, а также на течение заболевания. Методы. Полиморфные варианты гена GSTP1 анализировали методом аллель-специфической ПЦР с детекцией результатов в режиме реального времени. Результаты. Установлено, что гомозиготный тип наследования аллеля дикого типа – генотип A/A – ассоциирован с неблагоприятным прогнозом течения лимфомы Ходжкина: худшим ответом на лечение и вероятностью появления рецидивов. Выводы. Перспективным направлением поиска причин, обусловливающих течение болезни, является изучение полиморфизма гена GSTP1, который в будущем, возможно, будет использован как «фактор риcка» при формировании прогностических групп больных и выборе тактики лечения. 2012 Article The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients / I.A. Kriachok, N.M. Khranovska, N.M. Svergun, K.S. Filonenko, O.I. Novosad, I.B. Titorenko, A.V. Martynchik, H.O. Gubareva, T.V. Kadnikova, O.M. Aleksik, E.V. Kushchevyy, I.V. Pastushenko // Вiopolymers and Cell. — 2012. — Т. 28, № 1. — С. 56-61. — Бібліогр.: 19 назв. — англ. 0233-7657 DOI: http://dx.doi.org/10.7124/bc.00002D https://nasplib.isofts.kiev.ua/handle/123456789/156720 616-006.441:575.174.015.3. en Вiopolymers and Cell application/pdf Інститут молекулярної біології і генетики НАН України |
| institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| collection |
DSpace DC |
| language |
English |
| topic |
Biomedicine Biomedicine |
| spellingShingle |
Biomedicine Biomedicine Kriachok, I.A. Khranovska, N.M. Svergun, N.M. Filonenko, K.S. Novosad, O.I. Titorenko, I.B. Martynchik, A.V. Gubareva, H.O. Kadnikova, T.V. Aleksik, O.M. Kushchevyy, E.V. Pastushenko, I.V. The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients Вiopolymers and Cell |
| description |
The aim of this research was to study the influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients. Methods. The polymorphic variants of GSTP1 gene were analyzed using Allelic Discrimination Real-Time PCR. Results. The GSTP1 polymorphism is not directly involved in the development of Hodgkin’s lymphoma and chemotherapy-related toxicity, but homozygous wild genotype of this gene is associated with a worse clinical response to the therapy and a higher risk of relapse. Conclusions. The investigation of GSTP1 polymorphism is very promising, since it might provide a possible application of this genetic marker as an independent prognostic factor of Hodgkin’s lymphoma. |
| format |
Article |
| author |
Kriachok, I.A. Khranovska, N.M. Svergun, N.M. Filonenko, K.S. Novosad, O.I. Titorenko, I.B. Martynchik, A.V. Gubareva, H.O. Kadnikova, T.V. Aleksik, O.M. Kushchevyy, E.V. Pastushenko, I.V. |
| author_facet |
Kriachok, I.A. Khranovska, N.M. Svergun, N.M. Filonenko, K.S. Novosad, O.I. Titorenko, I.B. Martynchik, A.V. Gubareva, H.O. Kadnikova, T.V. Aleksik, O.M. Kushchevyy, E.V. Pastushenko, I.V. |
| author_sort |
Kriachok, I.A. |
| title |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients |
| title_short |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients |
| title_full |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients |
| title_fullStr |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients |
| title_full_unstemmed |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients |
| title_sort |
influence of gstp1 a313g polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of hodgkin’s lymphoma in ukrainian patients |
| publisher |
Інститут молекулярної біології і генетики НАН України |
| publishDate |
2012 |
| topic_facet |
Biomedicine |
| url |
https://nasplib.isofts.kiev.ua/handle/123456789/156720 |
| citation_txt |
The influence of GSTP1 A313G polymorphism on susceptibility, chemotherapy-related toxicity and prognosis of Hodgkin’s lymphoma in Ukrainian patients / I.A. Kriachok, N.M. Khranovska, N.M. Svergun, K.S. Filonenko, O.I. Novosad, I.B. Titorenko, A.V. Martynchik, H.O. Gubareva, T.V. Kadnikova, O.M. Aleksik, E.V. Kushchevyy, I.V. Pastushenko // Вiopolymers and Cell. — 2012. — Т. 28, № 1. — С. 56-61. — Бібліогр.: 19 назв. — англ. |
| series |
Вiopolymers and Cell |
| work_keys_str_mv |
AT kriachokia theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT khranovskanm theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT svergunnm theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT filonenkoks theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT novosadoi theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT titorenkoib theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT martynchikav theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT gubarevaho theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT kadnikovatv theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT aleksikom theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT kushchevyyev theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT pastushenkoiv theinfluenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT kriachokia doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT khranovskanm doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT svergunnm doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT filonenkoks doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT novosadoi doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT titorenkoib doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT martynchikav doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT gubarevaho doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT kadnikovatv doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT aleksikom doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT kushchevyyev doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT pastushenkoiv doslídžennâvplivupolímorfízmugenagstp1a313gnaviniknennâlímfomihodžkínatoksičnístʹhímíoterapíítaperebígzahvorûvannâ AT kriachokia issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT khranovskanm issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT svergunnm issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT filonenkoks issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT novosadoi issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT titorenkoib issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT martynchikav issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT gubarevaho issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT kadnikovatv issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT aleksikom issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT kushchevyyev issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT pastushenkoiv issledovanievliâniâpolimorfizmagenagstp1a313gnavozniknovenielimfomyhodžkinatoksičnostʹhimioterapiiitečeniezabolevaniâ AT kriachokia influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT khranovskanm influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT svergunnm influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT filonenkoks influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT novosadoi influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT titorenkoib influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT martynchikav influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT gubarevaho influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT kadnikovatv influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT aleksikom influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT kushchevyyev influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients AT pastushenkoiv influenceofgstp1a313gpolymorphismonsusceptibilitychemotherapyrelatedtoxicityandprognosisofhodgkinslymphomainukrainianpatients |
| first_indexed |
2025-11-25T20:56:21Z |
| last_indexed |
2025-11-25T20:56:21Z |
| _version_ |
1849797306142949376 |